Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?
Rukavina
D
D
Dept of Physiology and Immunology, Medical Faculty, University of Rijeka, Rijeka, HR-51000, Croatia.
Podack
E R
ER
D000818:Animals; D003656:Decidua / Q000276:immunology; D004622:Embryo, Mammalian / Q000276:immunology; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D007157:Immunologic Surveillance; D007694:Killer Cells, Natural / Q000378:metabolism; D008431:Maternal-Fetal Exchange / Q000187:drug effects / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000378:metabolism* / Q000494:pharmacology; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D011247:Pregnancy; D013602:T-Lymphocytes, Cytotoxic / Q000378:metabolism / Q000502:physiology*; D014327:Trophoblasts / Q000378:metabolism*
D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D054353:Perforin